Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

ALVOTECH SA — Lobbying — Receipts Report

LD-2 disclosure · 2nd Quarter - Report (No Activity)

ALVOTECH SA

via HOLLAND & KNIGHT LLP

2nd Quarter (Apr 1 - June 30) · 2026Posted Jul 15, 2026Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: ALVOTECH SA
Description: Biosimilar medicine development and manufacture
Location: Iceland

Registrant

Firm: HOLLAND & KNIGHT LLP
Description: Law Firm
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.